pancreatic cancer glutathione enhancement

pancreatic cancer glutathione enhancement depletion causes cell growth inhibition and enhanced apoptosis in cells - Schnelldorfer - 2000 - Cancer Targeting pancreatic cancer glutamine dependency

Name: pancreatic cancer glutathione enhancement depletion causes cell growth inhibition and enhanced apoptosis in cells - Schnelldorfer - 2000 - Cancer Targeting pancreatic cancer glutamine dependency
Brand: l2q2.es
SKU: 56552922367
Price: 26.87 USD
Availability: InStock
Rating: 4.2700000000000005 (30 reviews)

Targeting pancreatic cancer glutamine dependency confers vulnerability to GPX4 dependent ferroptosis: Cell Reports Medicine Ferroptosis: At the Crossroad of Gemcitabine Resistance and Tumorigenesis in Pancreatic Cancer Application of glutathione depletion in cancer therapy: Enhanced ROS based therapy, ferroptosis, and chemotherapy ScienceDirect Increased glucose availability sensitizes pancreatic cancer to chemotherapy bioRxiv

SKU: 56552922367 · From l2q2.es

4.3

USD26.87 USD53.87

Pay in 4 interest-free payments of $6.72 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 7 - Aug 12

Description

Nat Commun 2013;4:2019

identified that GHK-Cu upregulates approximately 4,000 genes and downregulates an additional 4,000, with clustered effects in pathways governing extracellular matrix synthesis, anti-inflammatory signaling, and DNA repair

Copper ions demonstrate more specific inhibition of type 1 5-alpha reductase compared to finasteride, which primarily targets the type 2 form, suggesting GHK-Cu may help reduce DHT's negative effects on follicles through this mechanism